{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:45:25Z","timestamp":1788583525331,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["23659530"],"award-info":[{"award-number":["23659530"]}]},{"name":"JSPS KAKENHI","award":["26461555"],"award-info":[{"award-number":["26461555"]}]},{"name":"Research Committee of spinal muscular atrophy (SMA)"},{"name":"Ministry of Health, Labor, and Welfare of Japan"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.bbrc.2014.09.087","type":"journal-article","created":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T16:11:04Z","timestamp":1411834264000},"page":"368-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry"],"prefix":"10.1016","volume":"453","author":[{"given":"Masayuki","family":"Arakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.09.087_b0005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0959-437X(02)00301-5","article-title":"The molecular bases of spinal muscular atrophy","volume":"12","author":"Frugier","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbrc.2014.09.087_b0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neuron sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2014.09.087_b0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.09.087_b0020","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.09.087_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/01.wnl.0000201929.56928.13","article-title":"SMN mRNA and protein levels in peripheral blood biomarkers for SMA clinical trials","volume":"66","author":"Sumner","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2014.09.087_b0030","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2014.09.087_b0035","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/01.wnl.0000313038.34337.b1","article-title":"A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy","volume":"71","author":"Nguyen thi Man","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2014.09.087_b0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.2009.200253","article-title":"Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid","volume":"82","author":"Piepers","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbrc.2014.09.087_b0045","doi-asserted-by":"crossref","first-page":"e24269","DOI":"10.1371\/journal.pone.0024269","article-title":"Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analyses","volume":"6","author":"Kobayashi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.09.087_b0050","doi-asserted-by":"crossref","first-page":"e33572","DOI":"10.1371\/journal.pone.0033572","article-title":"Pilot Study of Biomarkers for Spinal Muscular Atrophy Trial Group. Evaluation SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study","volume":"7","author":"Crawford","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.09.087_b0055","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/cyto.a.22116","article-title":"Detection of cytoplasmic nucleophosmin expression by imaging flow cytometry","volume":"81","author":"Grimwade","year":"2012","journal-title":"Cytometry A"},{"key":"10.1016\/j.bbrc.2014.09.087_b0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jcp.2010.085662","article-title":"PML protein analysis using imaging flow cytometry","volume":"64","author":"Grimwade","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbrc.2014.09.087_b0065","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","article-title":"A novel nuclear structure containing the survival of motor neurons protein","volume":"15","author":"Liu","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2014.09.087_b0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0092-8674(00)80368-2","article-title":"The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis","volume":"90","author":"Fischer","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.09.087_b0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2012.09.012","article-title":"An SMN-dependent U12 splicing event essential for motor circuit function","volume":"151","author":"Lotti","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.09.087_b0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/emmm.201202305","article-title":"Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds","volume":"5","author":"Cherry","year":"2013","journal-title":"EMBO. Mol. Med."},{"key":"10.1016\/j.bbrc.2014.09.087_b0085","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/jm061475p","article-title":"Synthesis and biological evaluation of novel 2.4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy","volume":"51","author":"Thurmond","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2014.09.087_b0090","doi-asserted-by":"crossref","first-page":"5ra12","DOI":"10.1126\/scitranslmed.3000208","article-title":"Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy","volume":"1","author":"Hastings","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2014.09.087_b0095","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2014.09.087_b0100","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2014.09.087_b0105","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1073\/pnas.95.11.6492","article-title":"Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural and tissues","volume":"95","author":"Francis","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.09.087_b0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-6-6","article-title":"A novel cell immunoassay to measure survival of motor neurons protein in blood cells","volume":"6","author":"Kolb","year":"2006","journal-title":"BMC Neurol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1401715X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1401715X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T10:09:13Z","timestamp":1565863753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1401715X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0006291X1401715X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.09.087","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.09.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}